Caspase-9 Protein <table class="infobox infobox-protein">Protein Name </td>Gene </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>Chromosome </td>Expression </td>
...
Caspase-9 Protein <table class="infobox infobox-protein">Protein Name </td>Gene </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>Chromosome </td>Expression </td>
Overview Caspase-9 (CASP9) is an initiator caspase that plays a central role in the intrinsic (mitochondrial) apoptosis pathway. Upon mitochondrial outer membrane permeabilization (MOMP), cytochrome c is released into the cytosol where it binds with Apaf-1 and dATP to form the apoptosome complex. This complex recruits and activates procaspase-9, initiating the caspase cascade that leads to apoptotic cell death. [@liang2021]
In neurodegenerative diseases, inappropriate activation of caspase-9 contributes to the progressive loss of neurons in Alzheimer's disease (AD), Parkinson's disease (PD), and other conditions. Caspase-9 deficiency has been shown to protect against AD pathology in mouse models, highlighting its pathogenic role. [@yuan2020]
Structure and Mechanism
Protein Architecture Caspase-9 is synthesized as a zymogen (procaspase-9) consisting of 416 amino acids. The active enzyme is generated through proteolytic cleavage at specific aspartate residues. [@hamacher1994]
Prodomain (1-125) : Contains the caspase recruitment domain (CARD) that mediates interaction with Apaf-1 in the apoptosome.Large Subunit (125-317) : Contains the catalytic cysteine residue (Cys287) and substrate-binding groove.Small Subunit (317-416) : Completes the active site and contributes to substrate specificity.
Activation Mechanism The apoptosome-mediated activation sequence: [@slee1999]
Apoptosome Formation : Cytochrome c + Apaf-1 + dATP → heptameric apoptosomeProcaspase-9 Recruitment : CARD-CARD interactions recruit procaspase-9 to the apoptosomeAutoactivation : Proximity-induced autoproteolysis at Asp315 and Asp330Tetramer Formation : Active caspase-9 (tetramer of two large + two small subunits)
Substrate Specificity Caspase-9 preferentially cleaves after DEXD sequences, with key substrates including:
Caspase-3 (executioner caspase)
Caspase-7 (executioner caspase)
PARP-1 (DNA repair)
XIAP (inhibitor of apoptosis)
Role in Neurodegenerative Diseases
Alzheimer's Disease Caspase-9 plays a critical role in AD pathogenesis through multiple mechanisms: [@yuan2020][@ekert1999]
Neuronal Apoptosis
Elevated caspase-9 activation in AD brain regions vulnerable to neurodegeneration
Contributes to amyloid-beta-induced neuronal death
Mediates tau cleavage and NFT formation
Evidence from Studies
Caspase-9 deficiency in APP/PS1 mice reduces amyloid pathology and improves cognition
Active caspase-9 colocalizes with amyloid plaques and neurofibrillary tangles
Cytochrome c release is enhanced in AD brains
Parkinson's Disease In PD, caspase-9 mediates dopaminergic neuron death through:
Mitochondrial Dysfunction
PINK1/PARKIN pathway impairment leads to MOMP
Enhanced susceptibility to mitochondrial toxins (MPTP, 6-OHDA)
Caspase-9 activation in substantia nigra of PD patients
Alpha-synuclein Toxicity
Caspase-9 cleaves alpha-synuclein, generating toxic fragments
Promotes Lewy body formation
Contributes to spreading of pathology
Other Neurodegenerative Conditions
ALS : Caspase-9 activation in motor neuronsHuntington's Disease : Mitochondrial dysfunction triggers caspase-9Prion Disease : PrPsc-induced apoptosis involves caspase-9Therapeutic Implications
Caspase Inhibitors
Challenges
Apoptosis vs. Development : Caspase-9 knockout mice are viable but show developmental abnormalitiesBBB Penetration : Most inhibitors do not cross the blood-brain barrierTiming : Intervention must occur before irreversible neuronal lossSelectivity : Pan-caspase inhibitors cause broad side effects
Alternative Strategies
Gene Therapy : AAV-delivered caspase-9 dominant-negative mutantsTargeted Delivery : Nanoparticle-based CNS deliveryModulation : Instead of complete inhibition, partial reduction of activityInteraction Network
Apoptosis Pathway Mitochondrial Stress → MOMP → Cytochrome c Release
Key Protein Interactions
See Also
[CASP9 Gene](/genes/casp9)
[Apoptosis Pathway](/mechanisms/apoptosis-pathway)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Cytochrome c](/proteins/cytochrome-c)
[Apaf-1 Protein](/proteins/apaf-1-protein)
External Links
[UniProt P55210](https://www.uniprot.org/uniprot/P55210)
[PDB: Caspase-9 Structures](https://www.rcsb.org/molecule/P55210)
[HGNC: CASP9](https://www.genenames.org/data/hgnc_data.php?hgnc_id=2141)
References
[Liang et al., Caspase-9 in COVID-19 and neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/33876108/)
[Yuan et al., Caspase-9 deficiency prevents AD pathology (2020)](https://pubmed.ncbi.nlm.nih.gov/32873834/)
[Hamacher et al., Cloning of human caspase-9 gene (1994)](https://pubmed.ncbi.nlm.nih.gov/9606212/)
[Slee et al., Ordering the cytochrome c-regulated caspases (1999)](https://pubmed.ncbi.nlm.nih.gov/10442631/)
[Ekert et al., Caspase-9, Bcl-2, and Alzheimer's disease (1999)](https://pubmed.ncbi.nlm.nih.gov/10530285/)
Show full description